Nabsys Highlights OhmX™ Platform's Ability to Accurately Verify Structural Variants in Undiagnosed Disorders and Workflow Optimizations at American Society of Hum…

Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, today presented new findings that highlight the ...

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 ...

Greater than 90% depletion of B cells within 12 hours of a single dose of AAN-14xMultiple redosing of AAN-14x at desired intervals with no ...

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
TMCnet

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
National Newswatch

Three things Canada’s health ministers could do to help Canadians with cancer

Canada’s health ministers can’t work miracles and magically fix all the problems in our health systems. But these are three ...

Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025

Preclinical data of FTX-6274 suggests potential for the treatment of castration resistant prostate cancer ―CAMBRIDGE, Mass., Oct. 14, 2025 ...

Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting

Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.

GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025

Populations Insights for GEO-CM04S1 in Immunocompromised Patients. ATLANTA, GA - October 9, 2025 (NEWMEDIAWIRE) - GeoVax ...
Le Lézard

NORD Breakthrough Summit Features Bold New Ideas for the Future of Rare Disease Care, Policy and Research

The future of rare disease advancements will take center stage at the National Organization for Rare Disorders (NORD®) Rare Disease and Orphan Products Breakthrough Summit®, Oct. 19-21 in ...